At the Institute of Nursing Research Nigeria, it is with great joy that we celebrate our dear CEO, Dr Akingbade Oluwadamilare, as he bags a PhD from the Nethersole School of Nursing, Chinese University, Hong Kong.
Dr Akingbade Oluwadamilare was recently honoured with two awards — Scholastic Excellence and Commitment In Chronic Illness Care and Outstanding Academic Performance in the preceding year of study by the Nethersole School of Nursing, Chinese University, Hong Kong.
A few weeks ago, he was also certified by The International Council of Nurses and CGFNS as a Global Nurse Consultant.
The Institute of Nursing Research, Nigeria, has become one of the largest nursing academic communities under his leadership, and its impact is felt not only in Nigeria but also across Africa and the world.
An inspiration, a mentor to many and a leader par excellence, Dr Akingbade is a dynamic community health specialist, passionate about impacting families and communities through research.
He is also committed to the growth of nurses, helping them build capacity through scholarly endeavours.
With his laudable achievements and feats, he has shown over and over again that nurses can do more.
We are proud of him, and once more, we say congratulations, Sir!
The Institute of Nursing Research, Nigeria, is delighted to celebrate seven years of continuous impact!
We have grown to become the largest nursing research organisation in Nigeria, and we couldn’t have come this far without our community and the many nurses worldwide who have contributed in one way or the other to our greatness.
Join us as we celebrate. There are scholarships to be awarded, exciting media challenges, and more.
Follow us on our social media pages for more updates: Twitter, LinkedIn, Instagram and Facebook.
Induction Program for INR Journal Club will be coming up on 24th of June, 2023.
You can still be a part of this cohort and enjoy the great benefits of being a member of IJC by registering via this link.
Registration has been extended and will close on 22nd June 2023.